ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 223 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q1 2023. The put-call ratio across all filers is 0.09 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $13,000 | -86.7% | 2,370 | -83.9% | 0.00% | – |
Q2 2023 | $98,000 | +22.5% | 14,689 | +62.4% | 0.00% | – |
Q1 2023 | $80,000 | -50.9% | 9,043 | -57.7% | 0.00% | – |
Q4 2022 | $163,000 | +328.9% | 21,388 | +298.5% | 0.00% | – |
Q3 2022 | $38,000 | -7.3% | 5,367 | +4.9% | 0.00% | – |
Q2 2022 | $41,000 | -63.1% | 5,117 | -36.2% | 0.00% | – |
Q1 2022 | $111,000 | -22.9% | 8,017 | +56.2% | 0.00% | – |
Q4 2021 | $144,000 | -27.6% | 5,132 | -12.5% | 0.00% | – |
Q3 2021 | $199,000 | -21.7% | 5,862 | -5.6% | 0.00% | – |
Q2 2021 | $254,000 | -58.4% | 6,212 | -59.0% | 0.00% | – |
Q1 2021 | $611,000 | +627.4% | 15,158 | +962.2% | 0.00% | – |
Q4 2020 | $84,000 | +110.0% | 1,427 | +75.3% | 0.00% | – |
Q3 2020 | $40,000 | -98.6% | 814 | -98.7% | 0.00% | -100.0% |
Q2 2020 | $2,952,000 | +69.6% | 61,003 | -2.7% | 0.00% | 0.0% |
Q1 2020 | $1,741,000 | +1972.6% | 62,682 | +2144.3% | 0.00% | – |
Q4 2019 | $84,000 | -75.6% | 2,793 | -75.0% | 0.00% | – |
Q3 2019 | $344,000 | +17.4% | 11,179 | +84.6% | 0.00% | – |
Q2 2019 | $293,000 | – | 6,055 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Blue Water Life Science Advisors, LP | 2,377,665 | $12,958,274 | 12.23% |
Eagle Health Investments LP | 1,214,860 | $6,620,987 | 1.46% |
Matrix Capital Management Company, LP | 11,572,590 | $63,070,616 | 0.76% |
Aristotle Atlantic Partners, LLC | 3,058,206 | $16,667,223 | 0.67% |
VIKING GLOBAL INVESTORS LP | 29,993,708 | $163,465,709 | 0.66% |
Pier Capital, LLC | 719,067 | $3,918,915 | 0.63% |
DDD Partners, LLC | 783,697 | $3,385,571 | 0.49% |
ARK Investment Management | 11,509,308 | $62,725,728 | 0.48% |
Nikko Asset Management Americas, Inc. | 6,570,939 | $35,680,199 | 0.43% |
Triatomic Management LP | 102,889 | $560,745 | 0.39% |